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Some Forms of cAMP-Mediated Long-Lasting
Potentiation Are Associated with Release of BDNF
and Nuclear Translocation of Phospho-MAP Kinase
Long-lasting synaptic plasticity, in contrast, requires the
initiation of gene transcription and protein synthesis
and, in at least some cases, involves the growth of new
synapses (Bailey et al., 1996; Bailey and Kandel, 1993).
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Cornell University cAMP induces the acute release of BDNF, thereby acti-
New York, New York 10021 vating the TrkB receptor signaling system, which then
activates MAPK signaling. We find, as previously re-
ported (Kang et al., 1997; Korte et al., 1998; Chen et al.,
1999), that BDNF is required for some forms of cAMP-
dependent long-lasting synaptic plasticity but not for
Summary others. Specifically, we find that BDNF is required for
the L-LTP produced by theta burst stimulation but not
Long-lasting forms of synaptic plasticity like the late
for the L-LTP produced by a strong 4-train stimulation
phase of LTP (L-LTP) typically require an elevation of
protocol. We also find that elimination of BDNF attenu-
cAMP, the recruitment of the cAMP-dependent protein
ates potentiation induced with forskolin, an adenylate
kinase (PKA), and ultimately the activation of tran-
cyclase activator that elevates intracellular cAMP andscription and translation; some forms also require
leads to transcription-dependent, long-lasting synapticbrain-derived neurotrophic factor (BDNF). Both cAMP
strengthening (Chavez-Noriega and Stevens, 1992; Huangand BDNF can activate mitogen-activated protein ki-
et al., 1994; Wang et al., 1999). Consistent with thesenase (MAPK/ERK), which also plays a role in LTP. How-
results, we observe that both forskolin- and theta burst-ever, little is known about the mechanisms whereby
induced potentiation lead to a very rapid activation ofcAMP, BDNF, and MAPK interact. We find that in-
TrkB, the BDNF receptor. In contrast, 4-train-inducedcreases in cAMP can rapidly activate the BDNF recep-
LTP, which is largely independent of BDNF, appears totor TrkB and induce BDNF-dependent long-lasting po-
be less efficient in activating TrkB in this system andtentiation at the Schaffer collateral-CA1 synapse in
does not lead to detectable TrkB activation at the timehippocampus. Surprisingly, in these BDNF-dependent
point examined. The rapid activation of TrkB receptorsforms of potentiation, which are also MAPK depen-
can be blocked with a BDNF scavenger, which suggestsdent, TrkB activation is not critical for the activation of
that BDNF is released, and that this BDNF plays anMAPK but instead appears to modulate the subcellular
instructive role.distribution and nuclear translocation of the activated
Although the BDNF-dependent forms of long-lastingMAPK.
potentiation examined here are also MAPK dependent,
we find that pharmacological blockade or genetic atten-
uation of the BDNF signaling does not significantly re-Introduction
duce the total activation of MAPK in response to potenti-
ating stimulation. Instead of activating MAPK, BDNFExperience-dependent modifications of synaptic strength
appears to modulate the translocation of the activatedare thought to underlie a variety of brain processes,
MAPK from the dendrites to the soma and then to theincluding both learning and memory and the activity-
nucleus. These results suggest that during the inductiondependent refinement of synaptic connections during
of some forms of long-lasting potentiation, cAMP maydevelopment. Studies in evolutionarily distant species,
ranging from Drosophila and Aplysia to mouse, have cause activation of the TrkB signaling system via re-
demonstrated that synaptic plasticity, like memory, has leased BDNF, which in turn induces translocation of
at least two forms. Short-term synaptic plasticity gener- activated MAPK to the nucleus, thereby modulating the
ally involves rapid modifications of existing proteins. access of MAPK to nuclear substrates (e.g., the tran-
scription factor CREB) that contribute to the persistence
of potentiation.5Correspondence: erk5@columbia.edu
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Results tion, percent baseline: saline  forskolin  136% 
13%, TrkB-Fc  forskolin  100%  6%; p  0.006).
This result indicates that some forms of cAMP-inducedDifferent Patterns of Stimulation Induce BDNF-
Dependent and -Independent Forms of L-LTP potentiation require neurotrophin-mediated signaling.
BDNF knockout mice have a marked deficiency in E-LTP
induced by two 100 Hz trains of stimuli (Patterson et TrkB Receptors Are Rapidly Activated by Stimuli
al., 1996). When we examined L-LTP in these mice, we Evoking BDNF-Dependent Forms of Long-
found, as previously reported (Kang et al., 1997; Korte Lasting Potentiation
et al., 1998; Chen et al., 1999), that BDNF contributes The role of BDNF in L-LTP could be permissive, instruc-
more to some forms of L-LTP than to others and that tive, or both. If BDNF is permissive, constitutive release
the pattern of stimulation determines the dependence of BDNF may be required to modulate other factors that
of the resulting potentiation on BDNF. Specifically, we are more directly involved in the induction of plasticity,
found that BDNF knockout mice had only a slight deficit such as synaptic vesicle docking machinery (Pozzo-
in L-LTP produced by a protocol of four 100 Hz trains Miller et al., 1999) or the function of the NMDA receptor
(Figure 1A; 4 hr after tetanus, percent baseline: homozy- (Suen et al., 1997; Jarvis et al., 1997). Alternatively, rapid
gotes  147%  8%; wild-types  188%  22%; p  activation of TrkB signaling may be directly involved in
0.09). However, BDNF knockout mice had a profound the induction of some forms of long-lasting plasticity
deficit in the response to a theta burst protocol (Figure and thus be instructive. Several studies have suggested
1B; 4 hr after tetanus, percent baseline: homozygotes  that hippocampal neurons can release neurotrophins
109%  6%; wild-types  158%  10%; p  0.006). or activate Trk receptors in response to prolonged or
Pharmacological removal of BDNF also reduced the intense stimulation (Blochl and Thoenen, 1995, 1996;
ability of a slice to respond to theta burst stimulation. Goodman et al., 1996; Binder et al., 1999; Aloyz et al.,
Hippocampal slices from wild-type mice were pre- 1999), but it is not clear whether this occurs normally
treated with a TrkB-Fc fusion protein (the ligand binding in response to more physiological plasticity-inducing
domain of the native TrkB receptor coupled to the Fc stimuli (reviewed in McAllister et al., 1999).
fragment of human immunoglobulin) that scavenges We therefore examined whether different stimulus
unbound TrkB ligands (Shelton et al., 1995). This treat- protocols that evoke long-lasting potentiation led to ac-
ment dramatically reduced potentiation in response to tivation of BDNF/TrkB signaling. Because of the diffi-
theta burst (Figure 1C; 4 hr after tetanus, percent base- culty of directly measuring release of endogenous
line: saline treated  170%  13%, TrkB-Fc treated  neurotrophins, particularly on a short timescale, we
113%  7%; p  0.006); TrkB-Fc treatment had no measured activation of the BDNF receptor TrkB. When
apparent effect on transmission in unpotentiated slices receptor tyrosine kinases like TrkB bind ligand, they
(after 4 hr of test stimuli, percent baseline: 97%  7%). dimerize, and this induces autophosphorylation (Guiton
et al., 1994; Schlessinger and Ullrich, 1992). Thus, we
examined TrkB receptor phosphorylation in stimulatedForskolin-Induced Potentiation Is Also Reduced
by a BDNF Scavenger slices (Figure 3).
We used 4-train, theta burst, and forskolin stimulationBoth the L-LTP induced by 4-train stimulation (Huang
et al., 1994; Abel et al., 1997) and that induced by theta to induce potentiation at the Schaffer collateral-CA1
synapse. A 4-train stimulation protocol, which inducesburst stimulation (Nguyen and Kandel, 1997) require an
elevation of cAMP and the activation of cAMP-depen- L-LTP that is not particularly dependent on BDNF, did
not evoke a detectable increase in phosphorylation ofdent protein kinase (PKA). We therefore also examined
a slowly developing, long-lasting form of potentiation TrkB (within 5 min of the last stimulus train). In contrast,
theta burst stimulation, a stimulus protocol that inducesinduced with forskolin, which elevates cAMP concentra-
tions by activating adenylyl cyclase (Chavez-Noriega BDNF-dependent L-LTP, evoked increased phosphory-
lation of the TrkB receptor very rapidly, within 5 minand Stevens, 1992; Huang et al., 1994; Wang et al., 1999;
Wong et al., 1999). Consistent with previous observa- of the stimulus (theta versus untetanized, p  0.05).
Similarly, treating slices with forskolin for 15 min, a treat-tions, we found that brief application (15 min) of forskolin
to slices pretreated only with saline produced long-last- ment that also produces a BDNF-dependent potentia-
tion, increased levels of phosphorylated TrkB in areaing potentiation, but application of 1,9-dideoxyforskolin
(an analog that does not activate adenylyl cyclase) did CA1 (p  0.05). Application of 1,9-dideoxyforskolin did
not significantly increase levels of phosphorylated TrkBnot (Figure 2; 4 hr after onset of drug application, percent
baseline: forskolin136%13%, 1,9-dideoxyforskolin (data not shown). Activation of TrkB by forskolin was
significantly reduced by removal of TrkB ligands by pre-89%  2%; p  0.05).
We next asked whether this cAMP-induced potentia- treatment with TrkB-Fc (p  0.03), demonstrating that
released ligand is required for the observed TrkB acti-tion requires BDNF-dependent signaling. To test this
idea, we pretreated the slices with TrkB-Fc to scavenge vation.
Although BDNF is not the only neurotrophin that canunbound ligand. We and others have found that BDNF
scavenging reagents persist in the slice after pretreat- bind the TrkB receptor and is therefore not the only
ligand scavenged by TrkB-Fc, BDNF is likely to be thement for at least 30 min (our unpublished data; Kang et
al., 1997) and thus will also scavenge neurotrophins primary molecule involved in the processes we observe
here. The other preferred TrkB ligand, NT-4/5, is in lowacutely released during forskolin application. We found
that the potentiation produced by forskolin was blocked abundance in the hippocampus (Timmusk et al., 1993;
Friedman et al., 1998). The neurotrophin NT-3 can bindby TrkB-Fc (Figure 2; 4 hr after onset of forskolin applica-
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Figure 1. L-LTP Induced by Some Types of Stimulus Patterns Is Reduced in BDNF Knockout Mice
Field EPSP slopes plotted as a percentage of pretetanus baseline for slices from wild-type and homozygous BDNF mutant mice tetanized
using one of two distinct protocols. (A) Four 1 s trains of stimuli, at 100 Hz, delivered 5 min apart or (B) 12 bursts of four pulses each, at 100
Hz, delivered 200 ms apart. Each point represents the mean SEM (n 8 slices, 7 mice for wild-type, and n 8 slices, 8 mice for homozygotes
in [A]; n  9 slices, 9 mice for wild-type, and n  6 slices, 5 mice for homozygotes in [B]). (C) L-LTP induced by theta burst stimulation is
also reduced in slices from wild-type mice by pretreatment with Trk-Fc, a BDNF scavenger. Slices were incubated in saline (n  4 slices, 4
mice) or TrkB-Fc (n  5 slices, 5 mice) for 1 hr prior to theta burst stimulation. TrkB-Fc control slices (n  2 slices, 2 mice) received only test
stimulation. In each panel, representative field potentials before and 4 hr after tetanization are shown on the top left; representative examples
of individual experiments are shown on the top right.
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Figure 2. Forskolin-Induced Potentiation Is
Reduced by Pretreatment with TrkB-Fc
Field EPSP slopes plotted as percentage of
baseline. Slices were pretreated with saline
or TrkB-Fc for 1 hr prior to treatment. Slices
pretreated with saline were then treated with
1,9 dideoxyforskolin (n  3 slices, 3 mice) or
forskolin (n  11 slices, 10 mice), and slices
pretreated with TrkB-Fc were treated with
forskolin (n  6 slices, 6 mice). Representa-
tive field potentials before and 4 hr after for-
skolin application are shown on the top left;
representative examples of individual experi-
ments are shown on the top right. The slight
rundown seen over time is attributable to the
pretreatment of the slices in an incubation
chamber (compare the forskolin-induced po-
tentiation seen here with that seen in slices
that were not preincubated in a separate in-
cubation chamber, shown in Figure 4). Incu-
bation in this separate chamber was neces-
sary in these experiments because TrkB-Fc
was not available in sufficient quantities to
permit continuous perfusion throughout the
1 hr preincubation.
TrkB but less efficiently than BDNF, and, again, NT-3 cellular clusters of TrkB in CA1 dendrites, which may
represent pools of receptor available for insertion intolevels in the CA1 region are comparatively low. Further-
more, the fact that several groups, including our own, the membrane [Drake et al., 1999]), our data suggest
that some BDNF is acutely released during the inductionhave obtained very similar effects on plasticity with
BDNF-blocking antibodies, TrkB-Fc treatment, and of BDNF-dependent forms of plasticity.
BDNF knockout strongly suggests that the majority of
the effects described here are due specifically to a re- Full Expression of BDNF-Dependent Forms of Long-
duction of BDNF binding to TrkB (Chen et al., 1999). Lasting Potentiation Requires MAPK, but BDNF
Several mechanisms could account for the increased Does Not Appear to Be a Major Activator of MAPK
activation of TrkB. Rapid increases in the phosphoryla- Like cAMP and BDNF, MAPK plays a role in synaptic
tion of TrkB could result either from acute, regulated plasticity (English and Sweatt, 1996, 1997; Martin et al.,
release of BDNF or from rapid insertion of additional 1997), and both cAMP and BDNF can lead to the activa-
TrkB into the cell membrane (increasing the pool of tion of MAPK (Martin et al., 1997; Roberson et al., 1999;
receptors available for activation), or from some combi- Meyer-Franke et al., 1998; Bonni et al., 1999), but the
nation of the two. It is also possible that there are activ- mechanisms by which MAPK is activated by stimuli that
ity-dependent alterations in the activity of a phospha- evoke long-lasting potentiation are unknown. We there-
tase acting on TrkB. Both regulated release of BDNF and fore explored whether BDNF activates MAP kinase in
rapid insertion of additional TrkB into the cell membrane BDNF-dependent forms of long-lasting potentiation.
have been observed in cell culture (Blochl and Thoenen, LTP induced by some protocols has been clearly
1995, 1996; Goodman et al., 1996; Binder et al., 1999, shown to require MAPK (English and Sweatt, 1997), but
Aloyz et al., 1999; Balkowiec and Katz, 2000; Meyer- this requirement has not been tested in the two forms
Franke et al., 1998; Du et al., 2000). We think it likely of BDNF-dependent forms of plasticity examined here.
that at least some of the activation we observe results We found that pretreatment of hippocampal slices with
from acute release of BDNF, for two reasons. First, the MAPK kinase (MEK) inhibitor UO126, like pretreat-
whereas significant TrkB receptor insertion has been ment with the BDNF scavenger TrkB-Fc, attenuated
observed 30–60 min after stimulation in cell culture theta burst-induced potentiation (Figure 4A; 4 hr after
(Meyer-Franke et al., 1998; Du et al., 2000), we observe tetanus, percent baseline: saline  theta  183% 
a dramatic increase in TrkB activation within 5 min of 17%, U0126  theta  125%  7%; p  0.02) but had
theta burst stimulation, which seems very rapid for the no effect on baseline transmission (after 4 hr of test
insertion of new receptors (although little is currently stimuli, percent baseline: 106%  5%). U0126 pretreat-
known about the kinetics of TrkB receptor insertion). ment also attenuated potentiation by forskolin (Figure
Second, we observe a 2- to 3-fold increase in phospho- 4B; 4 hr after tetanus, percent baseline: saline  for-
skolin  168%  18%, U0126  forskolin  123% TrkB after stimulation (Figure 3). For insertion of TrkB
to explain this magnitude of increase, the insertion of 12%). This demonstrates that full expression of theta
burst- and forskolin-induced potentiation, like certainTrkB would not only have to be very rapid, but also it
would have to be equal to the entire amount of TrkB other forms of cAMP-dependent plasticity (English and
Sweatt, 1997), requires activation of MAPK.already present in the membrane. While regulated inser-
tion of TrkB receptors is likely to be an important factor Forskolin treatment has been shown to lead to activa-
tion of MAPK, but the mechanism is unknown (Martin etin the physiological regulation of BDNF signaling on
somewhat longer timescales (we have observed intra- al., 1997; Roberson et al., 1999). If the forskolin-induced
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In BDNF-Dependent Forms of Plasticity, BDNF
Modulates the Subcellular Distribution
of Activated MAPK
If BDNF does directly influence MAPK signaling, as op-
posed to modulating plasticity at some point down-
stream of or parallel to MAPK, it must affect some other
aspect of the MAPK signaling process. One possibility
is modulation of the subcellular distribution of MAPK.
Activated MAPK translocates to the nucleus and is re-
quired for long-term facilitation in Aplysia, and phospho-
MAPK is increased in the nucleus after forskolin treat-
ment in mouse hippocampus (Martin et al., 1997). By
analogy, translocation of activated MAPK into the nu-
cleus may be required for L-LTP.
To investigate the possibility that BDNF regulates the
subcellular distribution of activated MAPK, we used im-
munohistochemistry to study the distribution of phos-
pho-MAPK in hippocampal neurons at various times
after the induction of potentiation. Because forskolin
provides strong, relatively homogeneous stimulation to
many synapses in a slice, making it easier to detect
subtle effects, we began by examining phospho-MAPK
in forskolin-potentiated slices. We first asked whether
reducing levels of BDNF altered the amount of phospho-
MAPK in the dendrites. As shown in Figure 6 and in
agreement with the results of the Western blots for
MAPK, the initial forskolin-induced activation of MAPK
did not appear to be greatly dependent upon the pres-
Figure 3. TrkB Receptors Are Rapidly Activated by Stimuli Evoking ence of BDNF. Phospho-MAPK levels were clearly in-
BDNF-Dependent Forms of Long-Lasting Potentiation
creased after 15 min of forskolin application as com-
Extracts of hippocampal slices immunoprecipitated with phospho-
pared to baseline (Figure 6, compare panels 6A and 6Btyrosine antiserum and immunoblotted with an antibody specific for
with 6C and 6D). At this time point, both the distributionTrkB. In each experiment, the CA1 regions of six to ten hippocampal
and levels of forskolin-evoked phospho-MAPK immuno-slices were microdissected and pooled to make each sample. All
experiments were repeated at least four times. Pretreatment with reactivity appeared comparable in slices pretreated with
the BDNF scavenger TrkB-Fc was used to block forskolin-induced vehicle and in slices pretreated with TrkB-Fc (Figure 6,
activation of TrkB. 4-train versus 4-train control, p  0.62, paired t compare panels 6C and 6D); there was no significant
test; theta burst versus theta burst control, p  0.05, paired t test;
difference in the number of dendrites stained for phos-theta burst versus 4-train, p  0.05, t test; n  4 experiments.
pho-MAPK (Figure 6K, p  0.94) or the overall areaForskolin versus saline, p  0.05, paired t test; n  4 forskolin, 4
occupied by stained dendrites (Figure 6L, p  0.35).saline, 2 dideoxyforskolin experiments. Forskolin versus TrkB-Fc 
forskolin, p  0.05, paired t test; n  4 experiments. Thirty minutes after the beginning of the forskolin
treatment, a very different pattern emerged. In slices
containing normal levels of BDNF, the spatial distribu-
tion of forskolin-evoked phospho-MAPK had shifted,increase in cAMP uses released BDNF to activate
with less activated MAPK present in the dendrites andMAPK, then removing free BDNF/TrkB ligands from the
more in the soma (Figure 6E). This shift was much lessslice should attenuate this activation. To test this idea,
apparent in slices that lacked BDNF as a result of treat-we prepared protein extracts from hippocampal slices
ment with TrkB-Fc (Figure 6F); more labeled dendritestreated with forskolin, vehicle control, or TrkB-Fc plus
were present after TrkB-Fc treatment than in the controlforskolin and analyzed them on Western blots using
(Figure 6, panels 6K and 6L, p 0.05 by both measures).an antibody specific for phosphorylated, and therefore
These differences in distribution remained but becameactive, MAPK (Figure 5). We found that levels of phos-
less apparent at later time points (Figure 6, comparepho-MAPK were increased by forskolin (forskolin versus
panels 6G and 6I with 6H and 6J) as levels of phospho-DMSO vehicle, p  0.015; forskolin versus 1,9-dideoxy-
MAPK declined.forskolin, p 0.04), consistent with the observation that
To independently confirm our observation about theMAPK activation is required for this form of potentiation.
consequences of removal of BDNF, we performed theHowever, to our surprise, the forskolin-induced increase
same experiment at the 30 min time point in slices fromin phospho-MAPK was not significantly reduced by
the BDNF knockout mice. Phospho-MAPK was consid-treatment with concentrations of TrkB-Fc that attenu-
erably increased by forskolin relative to the inactive ana-ated the forskolin-induced plasticity (2 g/ml; p 0.21).
log 1,9 dideoxyforskolin in both wild-type (Figures 7AHigher concentrations of TrkB-Fc (5 and 10 g/ml) were
and 7D) and knockout animals (Figures 7B and 7E); how-similarly ineffective (data not shown). This suggests that,
ever, in the knockouts, more of the activated MAPKwhile MAPK is recruited in BDNF-dependent forms of
remained in the dendrites (Figures 7A and 7B). Both theplasticity, the principal role of BDNF in this context is
number of immunoreactive dendrites in stratum radia-not direct activation of a significant percentage of the
recruited MAPK. tum (Figure 7C, p  0.01) and the overall area occupied
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Figure 4. A MAPK Kinase Inhibitor Reduces
Two Forms of TrkB-Dependent Long-Lasting
Potentiation
(A) Field EPSP slopes plotted as percentage
of baseline for slices incubated in saline (n 
6 slices, 6 mice) or UO126 (n  5 slices, 5
mice) for 1 hr prior to theta burst stimulation.
(B) Field EPSP slopes plotted as percentage
of baseline before treatment for slices treated
with forskolin alone (n  9 slices, 9 mice)
and for slices treated with UO126 followed
by forskolin (n  6 slices, 6 mice). Represen-
tative field potentials before and 4 hr after
stimulation are shown on the top left of each
panel; representative examples of individual
experiments are shown on the top right.
by stained dendrites (Figure 7F, p  0.05) were greater ghost,” where high signal in the cytoplasm outlined a
nucleus with little or no signal. To analyze the possibilityin the knockout.
As noted above, phospho-MAPK translocates to the that BDNF influences the nuclear translocation of MAPK,
we turned to paraffin-embedded, thin-sectioned po-nucleus and is required for long-lasting plasticity in
Aplysia; it may play a similar role in plasticity in the tentiated slices, which provide better preservation of
cytoarchitecture (Patterson et al., 1992).hippocampus (Martin et al., 1997). When the distribution
of phospho-MAPK within the cell bodies was examined As we had observed in Figures 6E and 6F, somatic
phospho-MAPK was clearly detectable 30 min after the30 min after forskolin treatment, the phospho-MAPK
appeared to be excluded from the nucleus more often onset of forskolin treatment (Figures 8B and 8C). As
before, nuclear ghosts were more frequently observedin slices treated with TrkB-Fc (Figures 6E and 6F) and
slices from BDNF knockouts (Figures 7A and 7B) than in TrkB-Fc-treated slices than in slices treated only with
forskolin (Figure 8, compare 8C and 8F with 8B andin controls. This apparent exclusion formed a “nuclear
BDNF-Mediated MAPK Nuclear Translocation and LTP
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Treatment with TrkB-Fc did not produce any significant
difference in total phospho-MAPK in the cell body layer
(arbitrary immunofluorescence intensity units: forsko-
lin  118.2%  11.8; forskolin  TrkB-Fc  108.5% 
4.7, p  0.45, t test). However, the slightly lower levels
of phospho-MAPK present in the cell body layer of the
TrkB-Fc-treated slices were consistent with more phos-
pho-MAPK remaining in the dendrites of these slices.
The ratio of nuclear to total pyramidal cell body layer
phospho-MAPK was significantly reduced in TrkB-Fc-
treated slices, consistent with a disruption of nuclear
translocation (ratio of nuclear to total pyramidal P-MAPK
signal intensity: forskolin  105%  3%; forskolin 
TrkB-Fc  93%  4%, p  0.01, t test). However, it is
important to note that phospho-MAPK containing nuclei
were sometimes seen in slices with reduced levels of
BDNF, and some nuclear ghosts were present in slices
with normal levels of BDNF. This implies that, while TrkB
activation is an important determinant of phospho-
MAPK localization, other, overlapping regulatory mech-
anisms probably exist.
Redistribution of Phospho-MAPK after Theta
Burst Potentiation Is Similarly Dependent
on TrkB Ligands
While forskolin potentiates large numbers of synapses
Figure 5. Forskolin-Induced Phosphorylation of MAP Kinase Is Not simultaneously and thus serves as a useful screen for
Reduced by TrkB-Fc
detecting normally subtle events associated with plas-
Representative anti-phospho-MAPK and anti-MAPK (detecting both
ticity, we also wanted to know whether TrkB ligandsthe phosphorylated and unphosphorylated forms) Western blots of
modulate the subcellular distribution of phospho-MAPKextracts made from three to five pooled hippocampal slices. Slices
in an electrically induced form of BDNF-dependent po-were pretreated with saline or TrkB-Fc for 1–2 hr. Slices were then
treated with vehicle, 1,9-dideoxyforskolin, TrkB-Fc, forskolin, or tentiation.
TrkB-Fc  forskolin for 15 min. Parallel Western blots with an anti- Paraffin-embedded sections provide excellent pres-
body detecting total MAPK served as loading controls. p  0.01 ervation of both cytoarchitecture and marks left by elec-
forskolin versus ACSF; p  0.05 forskolin versus 1,9-dideoxyfor-
trodes, making it possible to identify the stimulated sub-skolin; p  0.21 forskolin versus TrkB-Fc  forskolin; paired t test.
region of potentiated slices. Theta burst potentiationn  5 forskolin, 6 TrkB-Fc  forskolin, 5 DMSO, 3 TrkB-Fc, 3 1,9-
activated MAPK over untetanized levels (Figure 9, com-dideoxyforskolin.
pare 9A with 9B and 9C). More nuclear phospho-MAPK
was seen after theta burst stimulation than in control
slices which received only test stimuli (Figure 9, com-8E). Forskolin increased the amount of phospho-MAPK
immunoreactivity in the nuclei (Figure 8, compare 8A pare 9A and 9D with 9B and 9E); this demonstrates that
the observed increase in phospho-MAPK was due toand 8D with 8B and 8E). This increase was attenuated
by treatment with the BDNF scavenger TrkB-Fc (Figure the potentiating stimulation rather than to the test stimuli
or electrode damage. Furthermore, the increase in nu-8, compare 8B and 8E with 8C and 8F). These effects
were statistically significant when differences in back- clear phospho-MAPK evoked by theta burst, like the
forskolin-evoked increase, was reduced in TrkB-Fc-ground between independent experiments were taken
into account either in a two-way ANOVA with condition treated slices (Figure 9, compare 9B and 9E with 9C and
9F). Again, when interexperiment differences in back-and experiment as the independent measures (Figure
8J) or by normalizing to saline, in those experiments in ground were taken into account either in a two-way
ANOVA (with condition and experiment as the indepen-which all three conditions were represented (Figures 8K
and 8L). dent factors; Figure 9J) or by normalization to unpotenti-
ated controls (Figures 9K and 9L), both effects wereThis difference in levels of nuclear phospho-MAPK
could derive from a difference in nuclear translocation significant.
In theta burst-stimulated slices, as in forskolin-stimu-or from a cell-wide reduction in activated MAPK in the
absence of BDNF due to a subtle difference in phos- lated slices, the ratio of nuclear to total pyramidal cell
body layer phospho-MAPK was significantly reduced inphorylation or dephosphorylation. Our Phospho-MAPK
Western blot data (Figure 5) suggest that the differences TrkB-Fc-treated slices, consistent with a disruption of
nuclear translocation (ratio of nuclear to total pyramidalwe observe are probably not the result of a cell-wide
reduction in activated MAPK. However, to further distin- P-MAPK signal intensity: theta  107%  4%; theta 
TrkB-Fc  98%  1%, p  0.025, t test). This findingguish between these possibilities, we also quantitated
total phospho-MAPK activity in the pyramidal cell body strongly suggests that in theta burst potentiation, as
in forskolin-induced potentiation, BDNF modulates thelayer for each image; this measure includes phospho-
MAPK in both the nucleus and the somatic cytoplasm. access of activated MAPK to nuclear substrates.
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Figure 6. The Subcellular Distribution of Activated MAPK Is Altered in the Absence of TrkB Ligands
Slices were pretreated with physiological saline or TrkB-Fc and then stimulated with forskolin for 15 min. Immunoreactivity for phospho-MAPK
was examined in saline-treated slices (A and B) and in forskolin-treated slices 15 min (C and D), 30 min (E and F), 45 min (G and H), and 60
min (I and J) after the start of the treatment. After 15 min (C and D), TrkB-Fc caused little difference in phospho-MAPK distribution, but, at
30 min, there was a marked redistribution of phospho-MAPK signal to the cell body in the forskolin-treated slices (E) that was absent in the
TrkB-Fc/forskolin slices (F). Dendrites containing phospho-MAPK were quantitated by an observer (blind to treatment) using two different
methods (see Experimental Procedures for details): the number of labeled dendrites in stratum radiatum were counted for each image (K);
and the percentage of stratum radiatum occupied by labeled dendrites was quantitated using Metamorph (L). Using both measures, there
was a significant difference between ACSF-forskolin and TrkB-Fc-forskolin-treated slices over time (p 0.04; ANOVA with repeated measures).
Post-hoc analysis to determine the points at which this difference was significant confirmed that there was more phospho-MAPK in the
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Figure 7. The Subcellular Distribution of Activated MAPK Is Altered in BDNF Knockout Mice
Slices from mice homozygous for the BDNF knockout and wild-type littermates were treated with forskolin or 1,9-dideoxyforskolin for 15 min.
Immunoreactivity for phospho-MAPK was examined 30 min after the start of the treatment and quantitated as described in Figure 6. More
phospho-MAPK immunoreactivity was visible in dendrites 30 min after forskolin application in knockout mice (B) than in wild-type controls
(A). In animals of both genotypes, minimal activation was produced by 1,9-dideoxyforskolin (D and E). Scale bar  25 m. Quantitation
confirmed that there was a significant difference in dendritic phospho-MAPK between wild-types and knockouts (Experimental Procedures
as in Figure 6). The number of labeled dendrites in stratum radiatum was greater in knockouts than in wild-types (panel [C], p  0.01, t test;
n  5 experiments, 18 slices, 5 mice for homozygotes, n  21 slices, 6 mice for wild-types), as was the overall area occupied by stained
dendrites (panel [F], p  0.05, t test; n  5 experiments, 16 slices, 5 mice for homozygotes, n  15 slices, 6 mice for wild-types).
Both Presynaptic Terminals and Postsynaptic postsynaptic in the mouse than in the rat. This suggests
the interesting possibility that the relative contributionSpines Contain TrkB Receptors
Since the activation and translocation of MAPK in teta- of BDNF to pre- and postsynaptic mechanisms may
differ somewhat between rat and mouse. Such differ-nus-evoked L-LTP occurs postsynaptically, our results
are consistent with a postsynaptic action of BDNF. How- ences might partially explain reported differences in re-
sponse to BDNF at the Schaffer collateral-CA1 synapseever, other studies have suggested that BDNF can also
contribute to LTP through presynaptic mechanisms (reviewed in McAllister et al., 1999).
(Lessmann et al., 1994; Kang and Schuman, 1995;
Gottschalk et al., 1998; Li et al., 1998; Pozzo-Miller et al., Discussion
1999). These two possibilities are not mutually exclusive;
our data do not rule out an additional presynaptic contri- We have examined the interplay of three signaling path-
ways known to play a role in long-term synaptic plastic-bution of BDNF to L-LTP.
Indeed, we have previously found that full-length TrkB ity and long-term memory storage in the hippocampus:
cAMP, MAPK, and BDNF (for reviews, see Kandel andimmunoreactivity in the rat hippocampus is present both
presynaptically and postsynaptically, consistent with a Abel, 1995; Impey et al., 1999; Sweatt, 2001; McAllister
et al., 1999; Jankowsky and Patterson, 1999; and seerole for BDNF or other TrkB ligands in both components
of the synapse (Drake et al., 1999). However, the subcel- Minichiello et al., 1999). Our results suggest a model of
BDNF-dependent forms of long-lasting synaptic plastic-lular localization of some molecules differs significantly
between rats and mice (e.g., Herkenham and McLean, ity (Figure 11) in which stimuli like theta burst and for-
skolin recruit cAMP, which here serves two functions.1988). We therefore used immuno-EM to examine the
localization of full-length TrkB in our mice and again First, elevations in cAMP lead to the activation of MAPK
by an unknown mechanism. Second, elevations in cAMPfound that TrkB immunoreactivity is present both pre-
and postsynaptically at the Schaffer collateral-CA1 syn- can lead to the release of BDNF and activation of TrkB
signaling systems, which in turn promote the transloca-apse (Figure 10). Qualitative examination of the mouse
tissue suggested that more of the total TrkB label was tion of MAPK to the nucleus, providing access to sub-
dendrites of TrkB-Fc-forskolin-treated slices 30 min after forskolin (Duncan’s test, p  0.05 for both measures). For panel (K), forskolin-treated
slices, n  15, 13, 10, and 3 for 15, 30, 45, and 60 min, respectively; TrkB-Fc  forskolin-treated slices, n  12, 11, 8, and 4; ACSF, n  4,
3, 5, and 1; p  0.035 at 30 min; t test. For panel (L), n values differ slightly because of different exclusion criteria during scoring (as detailed
in Experimental Procedures); n  15, 13, 10, and 3 for forskolin treatment; n  12, 11, 6, and 6 for forskolin  TrkB-Fc; p  0.04 at 30 min;
t test. Scale bar  50 m.
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Figure 8. The Absence of TrkB Ligands Attenuates cAMP-Evoked Increases in Nuclear Phospho-MAPK
Slices were pretreated with physiological saline or TrkB-Fc and then stimulated with forskolin for 15 min. Immunoreactivity for phospho-MAPK
(30 min after the start of the forskolin treatment) was examined in paraffin-embedded, thin-sectioned slices. More phospho-MAPK signal was
apparent in nuclei in saline-pretreated, forskolin-treated slices (B and E) than in TrkB-Fc-pretreated, forskolin-treated slices (C and F). To
quantitate this effect, an observer blind to experimental condition manually outlined well-isolated and morphologically clear nuclei in phase
images with fluorescent nuclear counterstaining (G, H, and I), creating a template. The template was then superimposed on the phospho-
MAPK image, and the intensity of immunoreactivity within these outlined nuclei was quantitated using Universal Imaging Metamorph software
(see Experimental Procedures). (J) Raw nuclear phospho-MAPK (arbitrary fluorescence units, mean  SEM). More nuclear phospho-MAPK
was present in forskolin-treated slices than in TrkB-Fc-pretreated/forskolin-treated slices (main effect of TrkB-Fc treatment, p  0.02, two-
way ANOVA for TrkB-Fc treatment and experiment [to control for differences in background between experiments]: five experiments, containing
a total of nine forskolin-treated and nine TrkB-Fc/forskolin-treated slices). More nuclear phospho-MAPK was also present in forskolin-treated
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strates known to contribute to the persistence of poten- cAMP May Utilize TrkB Signaling Systems for
Some Forms of Long-Lasting Plasticitytiation (e.g., the transcription factor CREB—for a review
of candidate substrates, see Impey et al., 1999). Stimuli inducing long-lasting forms of plasticity typically
recruit cAMP and the cAMP-dependent protein kinaseThis model is based on three important results. First,
stimuli that induce forms of long-lasting synaptic plastic- PKA (Huang and Kandel, 1994; Nguyen and Kandel,
1997), which may contribute to long-lasting forms ofity dependent on both cAMP and BDNF evoke very rapid
BDNF-dependent activation of TrkB receptors, sug- plasticity in several ways (Bacskai et al., 1993; Blitzer
et al., 1995; Winder et al., 1998). For example, in long-gesting that BDNF actively contributes to the induction
of these forms of late-phase plasticity. Second, in- term facilitation in Aplysia, which resembles some as-
pects of L-LTP in the hippocampus, elevations of cAMPcreases in cAMP can induce this activation, suggesting
that one of the ways in which cAMP can contribute to activate PKA and lead to translocation of its catalytic
subunit into the nucleus, where it may phosphorylatelong-lasting potentiation is by triggering the release of
BDNF and the activation of TrkB receptors. Finally, in and activate transcription factors critical for long-lasting
facilitation (Bacskai et al., 1993). Cyclic AMP can alsothese forms of potentiation, TrkB activation is associ-
ated with modulation of the subcellular distribution and activate other signal transduction cascades, like the
MAPK cascade, in both Aplysia and rodents (Martin etnuclear translocation of activated MAPK rather than with
its activation. al., 1997; Vossler et al., 1997; Impey et al., 1998). Our
data suggest an additional mechanism by which cAMP
may produce some of its actions in long-lasting plastic-The BDNF Receptor TrkB Is Rapidly Activated
by Stimuli that Induce Neurotrophin-Dependent ity—by rapidly recruiting the BDNF/TrkB signaling
system.Forms of Long-Lasting Potentiation
Although BDNF is required for full expression of certain Both BDNF and MAPK may act downstream of and
in parallel to cAMP. Neurotrophins and cAMP synergisti-forms of plasticity, it has not been clear how it contrib-
utes to the signaling cascade leading to L-LTP. Is cally promote both growth and survival in PC12 cells
and in cultured cortical neurons (Gunning et al., 1981;BDNF’s role primarily permissive or instructive—is con-
stitutive release required for maintenance of the cellular Heidemann et al., 1985; Ghosh et al., 1994; Meyer-
Franke et al., 1995). BDNF can induce potentiation atsystems critical for the induction of plasticity, or, alterna-
tively, is BDNF signaling activated transiently and rapidly frog neuromuscular synapses in culture; this effect is
blocked by inhibitors and enhanced by activators ofas a component of the signal that induces L-LTP? If
BDNF is instructive, are its actions upstream, down- cAMP signaling (Boulanger and Poo, 1999). Similarly,
MAPK interacts synergistically with cAMP to promotestream, or in parallel to those of cAMP and MAPK?
Our data indicate that BDNF is likely to be instructive neuronal differentiation in PC12 cells (Yao et al., 1995).
Given that BDNF activates MAPK in retinal ganglionfor some forms of long-lasting synaptic plasticity. Both
electrical and pharmacological stimuli that produce (Meyer-Franke et al., 1998) and cerebellar granule cells
(Bonni et al., 1999), it seemed likely that cAMP mightBDNF-dependent potentiation lead to rapid activation
of TrkB. In addition, we show that TrkB activation after release BDNF to activate MAPK, perhaps as a part of a
coincidence detection system, in some forms of long-forskolin-induced potentiation is blocked by TrkB-Fc,
demonstrating that it requires released BDNF (and pos- lasting potentiation in the hippocampus.
sibly other TrkB ligands). Interestingly, the 4-train stimu-
lus protocol, which induces L-LTP that is not particularly
dependent on BDNF, does not produce detectable acti- MAPK Activation and Its Translocation
Are Regulated Separatelyvation of TrkB at the time point examined. This indicates
that rapid activation of TrkB is not a sign of pathology If cAMP releases BDNF to activate MAPK in BDNF-
dependent forms of synaptic plasticity, then both thetain the slices after tetanus or a general consequence
of activity. Instead, the correlation between the BDNF burst stimulation and forskolin treatment should lead to
the activation of MAPK. One would also predict thatdependence of different forms of long-lasting plasticity
and the efficiency of TrkB activation suggests that the treatment with the MAPK kinase (MEK) inhibitor UO126
or the BDNF scavenger TrkB-Fc should reduce bothactivation of TrkB reflects the recruitment of a specific
subset of the available signaling cascades for specific theta burst and forskolin-induced potentiation. This is
what we observed. Thus, we were surprised to find thatforms of long-lasting plasticity. There is precedent for
such a qualitative dissociation—for example, voltage- attenuation of BDNF signaling did not significantly re-
duce the activation of MAPK in response to forskolin.sensitive calcium channels (VSCCs) and N-Methyl-
D-aspartate (NMDA) receptor/channels underlie two In this system, elevations of cAMP must lead to MAPK
activation by other or additional means. For example,mechanistically distinct forms of LTP, are differentially
recruited by different electrical stimulus protocols, and elevations in cAMP might trigger the activation of the
small GTPase Rap1 (Vossler et al., 1997; de Rooij et al.,in turn recruit different downstream kinases (Grover and
Teyler, 1990, 1995; Cavus and Teyler, 1996). 1998; Kawaski et al., 1998) or the switching of coupling
slices than in saline-treated slices (main effect of forskolin treatment, p  0.0025; two-way ANOVA for forskolin treatment and experiment:
three experiments, containing a total of seven forskolin-treated, four saline-treated slices). (K) Values for forskolin-stimulated slices normalized
to unstimulated saline controls; p  0.05. Data are plotted only for the subset of experiments for which saline controls were available (some
slices were lost during processing). (L) Cumulative probability histogram of normalized nuclear phospho-MAPK in individual sections. The
ordinate represents the total probability that nuclei will contain phospho-MAPK signal falling within a particular range.
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Figure 9. Increases in Nuclear Phospho-MAPK Evoked by Theta Burst Are Also Reduced by TrkB-Fc
Phospho-MAPK immunoreactivity was examined in paraffin-embedded, thin-sectioned slices. Theta-stimulated slices (B and E) showed more
nuclear phospho-MAPK than TrkB-Fc-pretreated theta-stimulated slices (C and F) or slices subjected to only test stimuli (A and D). As in
Figure 8, phase contrast images and nuclear staining (superimposed in [G], [H], and [I]) were used to select and define the outlines of the
nuclei from which nuclear phospho-MAPK signal was quantitated. (J) Raw nuclear phospho-MAPK (arbitrary fluorescence units, mean 
SEM). TrkB-Fc pretreatment markedly reduced the nuclear localization of phospho-MAPK following tetanus (main effect of treatment, p 
0.005, two-way ANOVA for treatment and experiment; by Duncan’s post-hoc test: p  0.0025 for theta versus TrkB-Fc/theta; p  0.01 for
theta versus unstimulated; p  0.2 for TrkB-Fc/theta versus unstimulated; four experiments, containing a total of eight theta slices, five TrkB-
Fc/theta slices, four unstimulated slices). (K) Values for tetanized slices normalized to untetanized controls. p 0.005. (L) Cumulative probability
histogram of normalized nuclear phospho-MAPK in individual sections. The ordinate represents the total probability that nuclei will contain
phospho-MAPK signal falling within a particular range. *, p  0.05 compared to theta burst.
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nucleus (Martin et al., 1997). Consistent with the idea
that BDNF might regulate the translocation rather than
the activation of MAPK, we found that pharmacological
or genetic removal of BDNF reduced the redistribution
of forskolin-activated MAPK from the dendrites to the
cell body. Similarly, treatment with the BDNF scavenger
TrkB-Fc reduced the increase in nuclear phospho-
MAPK evoked by forskolin or theta burst stimulation.
Together, our data strongly suggest that TrkB signaling
is an important regulator of phospho-MAPK redistribu-
tion during the induction of certain forms of plasticity.
Interestingly, the cAMP-dependent protein kinase PKA
is required for nuclear translocation of activated MAPK
in PC12 cells (Impey et al., 1998). Thus, it is possible that
PKA sometimes recruits BDNF to modulate the nuclear
translocation of activated MAPK.
How might BDNF regulate the subcellular distribution
of activated MAPK? Perhaps BDNF mediates subtle dif-
ferences in phosphorylation of MAPK, which in turn
modulate the subcellular distribution of the activated
kinase. It has been hypothesized that MEK, the up-
stream activator of p42/p44 MAPK, might form part of
a cytoplasmic anchoring complex (Lenormand et al.,
1998). BDNF might disrupt such an anchoring complex,
freeing the activated kinase to translocate. Alternatively,
there could be spatially distinct pools/complexes of
MAPK, with activation of one leading to phosphorylation
of cytoplasmic substrates, and activation of the other,
phosphorylation of nuclear substrates. In yeast, MAPK
pathways form modules held together by protein-pro-
tein interactions; these modules appear to provide spa-
tial regulation of MAPK pathways (Widmann et al., 1999).
Thus, BDNF might shift activation to a more translocat-
able pool of MAPK. It is also possible that TrkB signaling
in some way promotes the retention of activated MAPK
in the nucleus. Studies in fibroblasts suggest that nu-
clear accumulation of p42/p44 MAPK is dependent on
the synthesis of short-lived proteins, possibly nuclear
anchors, induced by activation of p42/p44 MAPK (Le-
normand et al., 1998).
Figure 10. TrkB Immunoreactivity Is Present in Both Axon Terminals
There Are Multiple Forms of L-LTP with Distinctand Dendritic Spines
Molecular Mechanisms(A) A TrkB-labeled dendritic spine (TrkB-sp) emerges from an unla-
Our model of BDNF-dependent forms of cAMP-depen-beled dendritic shaft in stratum radiatum.
(B) In a labeled spine (TrkB-sp), TrkB is concentrated along the dent synaptic plasticity has several important implica-
plasma membrane near the synapse (curved arrow), while TrkB la- tions. First, complex cellular processes such as synaptic
beling in a nearby dendritic shaft (TrkB-d) is primarily around intra- plasticity result not from simple linear molecular cas-
cellular organelles.
cades but from the integration of networks of multiple(C) Presynaptic TrkB labeling in an excitatory-type axon terminal
signaling systems. Second, there are multiple forms of(TrkB-t) that forms an asymmetric synapse (curved arrow) with an
L-LTP, so experiments using different protocols andunlabeled spine. A neighboring axon is also labeled (TrkB-a). Scale
bar  0.5 m. different experimental preparations may not converge
on the same set of molecular mechanisms (Sanes and
Lichtman, 1999), although there will undoubtedly be
many commonalities. Third, it will be important to iden-of the 2 adrenergic receptor (Daaka et al., 1997) or the
release of growth factors other than BDNF. tify which specific mechanisms are recruited under phys-
iological conditions and by different learning paradigms,How might BDNF contribute to long-lasting potentia-
tion in the hippocampus, if not by activation of MAPK? in order to appreciate which forms of experimentally
induced plasticity have the most relevance for particularIn addition to being regulated by phosphorylation, the
actions of MAPK in cultured cells can be regulated by forms of learning and memory. Finally, the existence
of different forms of L-LTP suggests that they may bemodulation of its subcellular distribution (Lenormand
et al., 1993; Widmann et al., 1999). For example, its invoked under different circumstances—perhaps regu-
lated by modulatory transmitters or growth factors, be-participation in the induction of long-lasting facilitation
in Aplysia apparently requires its translocation to the havioral state, attention, or other variables. Such a rich
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Figure 11. A Model Whereby BDNF May Contribute to Some Forms of Long-Lasting Potentiation
Levels of cAMP are elevated in response to stimuli evoking BDNF-dependent forms of long-lasting potentiation. The increase in cAMP activates
the MAPK pathway by an unknown mechanism, as discussed in the text. The elevation of intracellular cAMP may also trigger a rapid increase
in activation of TrkB through the rapid release of BDNF (or other TrkB ligands), the rapid insertion of additional TrkB receptors into the
membrane for activation, or both. BDNF is likely to have presynaptic effects, such as modulation of transmitter release. However, BDNF also
has postsynaptic actions, modulating nuclear translocation of the activated MAP kinase, which may also contribute to long-lasting potentiation.
In the presence of BDNF, therefore, activated MAPK may act on nuclear targets (e.g., the transcription factor CREB) important for the
persistence of some forms of potentiation; in the absence of BDNF, activated MAPK may have reduced access to the nucleus.
the death of the homozygotes. Animals were genotyped using arepertoire of molecular mechanisms may greatly in-
PCR-based assay (Ernfors et al., 1994).crease the computational power and flexibility of learn-
ing algorithms.
Slice Preparation
Hippocampi were collected from mice after cervical dislocation.Experimental Procedures
Conventional techniques were used to prepare transverse hippo-
campal slices (400m) (Patterson et al., 1996). Slices used for physi-BDNF Knockout Mice
ology were maintained in an interface chamber at 28C and perfusedThe BDNF mutant mice were bred in our colony, which is derived
with an oxygenated saline solution (in mM: 124.0 NaCl, 4.4 KCl, 26.0from heterozygote mutant mice provided by P. Ernfors and R. Jae-
NaHCO3, 1.0 NaH2PO4, 2.5 CaCl2, 1.3 MgSO4, 10 glucose). Slicesnisch (Ernfors et al., 1994). The original BDNF knockout was main-
were permitted to recover from cutting for at least 90 min beforetained on a mixed 129/ter SV and BALB/c genetic background (Ern-
recordings were begun. To record field excitatory postsynaptic po-fors et al., 1994). All of the BDNF mutant and wild-type mice used
tentials in the CA1 region of the hippocampus, the stimulating andin these studies were descended from mice produced by crossing
recording electrodes were both placed in the stratum radiatumheterozygous BDNF knockout mice with the original mixed 129/ter
of CA1.SV and BALB/c genetic background with wild-type C57BL/6J mice.
The phenotype of the BDNF knockout on the new genetic back-
ground was similar to the phenotype of the BDNF knockout on the Stimulation Protocols for Physiology
Because the BDNF mutant mice used in these studies had a deficit inoriginal mixed 129/ter SV and BALB/c genetic background (Pat-
terson et al., 1996). However, the survival time of the homozygotes basal synaptic transmission (Patterson et al., 1996), in experiments
using both BDNF mutant and wild-type mice, stimuli were deliveredwas improved (from 3.5 weeks on the original background to 5
weeks on the new background). Wild-type and homozygote BDNF at intensities that evoked field EPSP slopes equal to 1mV/ms in all
slices. For all other physiology experiments, stimuli were deliveredmutant mice were examined between 2.5 weeks, soon after the
slices become capable of producing LTP, and 4.5 weeks, before at intensities that evoked field EPSP slopes equal to 1/3 of the
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maximum in each slice. Test stimuli were delivered every 2 min, and 0.5 mM sodium vanadate, 0.1% 2-mercaptoethanol, 1% Triton
X-100, 50 mM sodium fluoride, 5 mM sodium phosphate, 10 mMtest responses were recorded for 15–30 min prior to beginning the
experiment to assure stability of the response. Slices were tetanized glycerophosphate, 0.1 mM PMSF. Protein (25 g) from each lysate
was separated in 10% SDS-PAGE, transferred to nitrocelluloseusing one of two protocols: either four trains of stimuli, each 1 s,
at 100 Hz, delivered 5 min apart; or 12 bursts, of four pulses at 100 membrane, and probed with polyclonal antibodies specific to either
double-phosphorylated p44 and p42 MAPK (New England Biolabs)Hz, delivered 200 ms apart. Both of these protocols induce L-LTP
in wild-type mice of this genetic background. The same stimulus or to total p44 and p42 MAPK (New England Biolabs) following
manufacturer’s protocol. HRP-anti-rabbit conjugate (New Englandintensity was used for tetanization and evoking test responses.
Slices were potentiated pharmacologically by perfusing with 50 M/ Biolabs) was used as secondary antibodies at a 1:5000 dilution. The
MAPK bands were visualized by chemiluminescence using Lumi-ml forskolin in DMSO (0.1% of final volume) for 15 min. Responses
were recorded for 4 hr at 0.01 Hz after tetanization or stimulation GLO reagent (New England Biolabs). Densiometric analysis of immu-
noreactivity for phosphorylated p44 and p42 MAPK or for total p44with forskolin.
and p42 MAPK was conducted using a Molecular Dynamics Per-
sonal Densitometer SI and Molecular Dynamics ImageQuant soft-Treatment with TrkB-Fc
Freshly cut slices from 3.5- to 4.5-week-old wild-type mice were ware. Phospho-MAPK immunoreactivity was normalized to total
MAPK immunoreactivity.incubated submerged in either oxygenated saline alone or 2 g/ml
TrkB-Fc (generous gift of Regeneron) in oxygenated saline, at 28C
for 1–1.5 hr prior to use for physiology or immunochemistry. Slices Statistical Analysis
for physiology were then moved to the interface recording chamber All statistical analysis was performed using Statistica (Statsoft,
and allowed 10 min to recover prior to starting recordings. Some 1996). Comparisons of two groups were done by t test (paired where
slices for immunochemistry were treated for 15 min with 50 M/ml indicated). Three or more group comparisons were conducted using
forskolin (CalbioChem) in DMSO, or controls including 50 M/ml 1,9 ANOVA with Duncan’s post-hoc tests.
dideoxyforskolin (CalbioChem) in DMSO, DMSO in saline, or saline
solution alone. Some slices for immunochemistry were stimulated Immunocytochemistry and Confocal Microscopy
using theta burst or test stimuli alone (see above). Slices were fixed in 4% paraformaldehyde. Phosphatase inhibitors
(1 mM sodium orthovanadate and 1 mM sodium fluoride) were in-
Treatment with MAPK Kinase Inhibitors cluded in all subsequent solutions. Slices were permeabilized with
Slices were pretreated in the interface recording chamber for 1 hr 0.2% Triton X-100, quenched with 50 mM NH4Cl, and blocked with
with a membrane-permeable MAPK kinase (MEK) inhibitor, UO126 10% goat serum. Slices labeled with phospho-MAP kinase antibod-
at 20 M (Research Biochemicals International) dissolved in DMSO ies (New England Biolabs) were incubated overnight with the primary
(0.1% of final volume) then diluted in ACSF. UO126 treatment was antisera (1:100 in 10% goat serum in PBS). After extensive washing
continued during the 15 min forskolin treatment and maintained for in PBS, slices were incubated at 4C overnight with the secondary
15 min after the start of the forskolin washout. antibody conjugated to Cy3 (1:200 in 10% goat serum in PBS). The
slices were washed 4–6 hr in PBS before imaging. Images were
Immunoprecipitations with Phosphotyrosine Antibodies taken using a BioRad MRC 1000 confocal microscope with a 15mV
and Western Blotting for TrkB Krypton/Argon laser attached to a Zeiss Axiovert 100 with a 40	,
Slices of mouse hippocampus were prepared as described above. 0.75 n.a. long working distance objective. Kalman-averaged images
In experiments involving tetanized slices, the slices were removed of eight scans were analyzed for Cy3 fluorescence at 568 nm with
from the recording chamber 5 min after the last stimulus was deliv- 10% laser light using BioRad’s imaging software Comos. The same
ered. In experiments involving drugged slices, slices were removed settings were used for all images.
15 min after the onset of the drug treatment. Slices were then rapidly
frozen on dry ice, and the CA1 region was microdissected out. Each Quantitation of Dendrites in Confocal Images
sample in each of these experiments was made from six to ten Dendrites positive for Phospho-MAPK were quantitated by an ob-
pooled slices. All samples were homogenized in a plastic Dounce server blind to treatment using two techniques.
homogenizer in lysis buffer (1	 PBS, 0.5% Triton X-100, 2 mM Na-
• To count “number of labeled dendrites” (see Figures 6K and 7C),Orthovanadate, 2 mM Na-floride). Protein concentration in the ex-
images were digitally contrast stretched for maximum resolutiontracts was measured using a Pierce Micro BCA Protein Assay Kit.
of phospho-MAPK-positive dendrites. Dendrites entering a bandHippocampal extracts were immunoprecipitated with phospho-
in stratum radiatum parallel to, of about the same width as, andtyrosine antisera (BD Transduction Laboratories). The extracts and
about two cell body diameters away from stratum pyramidalea bovine serum albumin control were incubated with the antisera
were counted for each image. Generally, four to eight images ofat 4C for 1 hr. Protein A coupled Agarose beads (BD Transduction
each slice were averaged to determine a value for the slice. Im-Laboratories) in PBS with phosphotyrosyl-phosphatase inhibitors
ages were excluded if background was unacceptably high or if(2 mM Na-Orthovanadate, 2 mM Na-floride) were added to the ex-
the tissue was obviously damaged. Images where cell bodiestracts, and the mixture was incubated at 4C for 1 hr. The beads
were visible but dendrites were not were counted as zero.were then washed three times (1	 PBS, 0.5% Triton X-100, 0.2 mM
• To determine the “percentage of stratum radiatum occupied byNa-Orthovanadate, 0.2 mM Na-floride). The washed beads were
labeled dendrites” (see Figures 6L and 7F), images were analyzedthen resuspended in 2	 sample loading buffer and boiled for 5 min.
using Metamorph (version 4.1.3, Universal Imaging Corporation,The supernatant was then size fractionated on an 8% Tris-glycine
2000). Stratum radiatum was selected using anatomical criteria,SDS-polyacrylamide gel. The proteins were transferred to Nitrocellu-
excluding obvious artifacts. Images were thresholded to maximizelose membranes, and the blots were blocked with BLOTTO (PBS,
the contrast of dendrites within the selected region. The reported0.1% Tween 20, 5% nonfat dry milk) for 30–60 min at room tempera-
measure represents the percentage area of stratum radiatum oc-ture. The blots were then incubated overnight at 4C with rabbit
cupied by phospho-MAPK-positive dendrites (i.e., above thresh-anti-TrkB (BD Transduction Laboratories) diluted 1:1000 in BLOTTO.
old). It was computed by dividing the area within stratum radiatumThe blots were washed in BLOTTO at room temperature and then
in which the signal was above threshold by the total selectedincubated for 1–2 hr at room temperature with a horseradish peroxi-
area. Again, where multiple images were available for a singledase-labeled goat anti-Rabbit IgG (New England Biolabs). Bands
slice, they were averaged. Images with no visible dendrites, un-were visualized using enhanced chemiluminescence (Pierce). Densi-
usually high background, or obvious anatomical damage wereometric analysis of TrkB immunoreactivity was conducted using a
excluded.Molecular Dynamics Personal Densitometer SI and Molecular Dy-
namics ImageQuant software.
Immunocytochemistry of Paraffin Sections
Sections were embedded in paraffin and analyzed by a variation onWestern Blotting for MAPK and Phospho-MAP Kinase
the method of Patterson et al. (1992). Hippocampal slices (400 m)Five slices from each treatment were homogenized in 300 l of a
buffer containing 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM EGTA, were prepared and potentiated in the presence or absence of TrkB-
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Fc, as described above. Slices were collected and fixed overnight Elite kit; Vector) at twice the recommended dilution in TS for 30 min
at room temperature. Tissue was rinsed in TS between incubations.in methyl carnoy (60% methanol, 30% choloroform, 10% acetic
acid). Slices were dehydrated through graded alcohols, cleared Immunolabeling was visualized by incubating sections in PB con-
taining 3,3
-diaminobenzidine (DAB, 0.22%) and hydrogen peroxideovernight in methyl salicylate (Sigma), embedded in paraffin, sec-
tioned at 8 m on a microtome, floated onto microscope slides (0.00003%).
Labeled sections were fixed in 2% osmium tetroxide in PB for 1(Fisher, SuperFrost Plus), and dried overnight at 37C. Slides were
deparafinized in d-Limolene (Stephens Scientific), rehydrated hr, rinsed in PB and dehydrated through a series of ethanols and
propylene oxide, and flat embedded in EMBed between two sheetsthrough graded ethanols, incubated in PBS, blocked in PBS/10%
goat serum (Sigma), and immunostained with anti-phospho MAPK of Aclar plastic. Immunolabeled regions of the CA1 region of hippo-
campus were glued onto Epon blocks. Ultrathin (60 nm) sections(NEB/Cell Signaling Technologies, 1:1000 in PBS/goat serum).
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